Biotricity Management
Management criteria checks 2/4
Biotricity's CEO is Waqaas Al-Siddiq, appointed in Jul 2014, has a tenure of 10.17 years. total yearly compensation is $1.25M, comprised of 38.3% salary and 61.7% bonuses, including company stock and options. directly owns 3.46% of the company’s shares, worth $324.25K. The average tenure of the management team and the board of directors is 6.9 years and 7 years respectively.
Key information
Waqaas Al-Siddiq
Chief executive officer
US$1.3m
Total compensation
CEO salary percentage | 38.3% |
CEO tenure | 10.2yrs |
CEO ownership | 3.5% |
Management average tenure | 6.9yrs |
Board average tenure | 7yrs |
Recent management updates
Recent updates
Investors Give Biotricity, Inc. (NASDAQ:BTCY) Shares A 38% Hiding
Jan 26Many Still Looking Away From Biotricity, Inc. (NASDAQ:BTCY)
Oct 26Biotricity GAAP EPS of -$0.09, revenue of $2.06M
Aug 15Biotricity, Inc.: A First Take
Jul 28Is Biotricity (NASDAQ:BTCY) Using Debt In A Risky Way?
Apr 09Does Biotricity (NASDAQ:BTCY) Have A Healthy Balance Sheet?
Dec 11Biotricity: Capital Raise Leads To Buying Opportunity
Aug 31CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$18m |
Mar 31 2024 | US$1m | US$480k | -US$15m |
Dec 31 2023 | n/a | n/a | -US$15m |
Sep 30 2023 | n/a | n/a | -US$17m |
Jun 30 2023 | n/a | n/a | -US$18m |
Mar 31 2023 | US$1m | US$480k | -US$20m |
Dec 31 2022 | n/a | n/a | -US$21m |
Sep 30 2022 | n/a | n/a | -US$23m |
Jun 30 2022 | n/a | n/a | -US$29m |
Mar 31 2022 | US$887k | US$480k | -US$30m |
Dec 31 2021 | n/a | n/a | -US$30m |
Sep 30 2021 | n/a | n/a | -US$27m |
Jun 30 2021 | n/a | n/a | -US$19m |
Mar 31 2021 | US$891k | US$390k | -US$16m |
Dec 31 2020 | n/a | n/a | -US$16m |
Sep 30 2020 | n/a | n/a | -US$14m |
Jun 30 2020 | n/a | n/a | -US$13m |
Mar 31 2020 | US$2m | US$390k | -US$11m |
Dec 31 2019 | n/a | n/a | -US$8m |
Sep 30 2019 | n/a | n/a | -US$8m |
Jun 30 2019 | n/a | n/a | -US$8m |
Mar 31 2019 | US$2m | US$360k | -US$9m |
Dec 31 2018 | n/a | n/a | -US$10m |
Sep 30 2018 | n/a | n/a | -US$9m |
Jun 30 2018 | n/a | n/a | -US$9m |
Mar 31 2018 | US$1m | US$310k | -US$9m |
Compensation vs Market: Waqaas's total compensation ($USD1.25M) is above average for companies of similar size in the US market ($USD681.57K).
Compensation vs Earnings: Waqaas's compensation has increased whilst the company is unprofitable.
CEO
Waqaas Al-Siddiq (39 yo)
10.2yrs
Tenure
US$1,254,153
Compensation
Dr. Waqaas Al-Siddiq, PhD, has founded Biotricity Inc.(formerly known as iMedical Innovations Inc.) in July 2014 and has been its Chairman, President and Chief Executive Officer since July 2014. Dr. Al-Sid...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 10.2yrs | US$1.25m | 3.46% $ 324.3k | |
Chief Financial Officer | 6.9yrs | US$562.00k | 1.21% $ 113.2k | |
Senior Director of Operations | no data | no data | no data | |
Director of Business Development | no data | no data | no data | |
Vice President of Sales & Strategy | no data | no data | no data | |
Chief Development Officer | no data | no data | no data | |
Senior Vice President of Healthcare Solutions | less than a year | no data | no data |
6.9yrs
Average Tenure
Experienced Management: BTCY's management team is seasoned and experienced (6.9 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 10.2yrs | US$1.25m | 3.46% $ 324.3k | |
Chair of Scientific & Medical Alliance Board and Chair of Science Alliance Board | 4.5yrs | no data | no data | |
Member of the Board of Advisors | 8.3yrs | no data | no data | |
Independent Director | 2.3yrs | US$32.62k | 0.16% $ 14.6k | |
Independent Director | 8.3yrs | US$60.00k | 1.32% $ 123.6k | |
Member of the Board of Advisors | 8.3yrs | no data | no data | |
Member of the Board of Advisors | 8.3yrs | no data | no data | |
Member of the Board of Advisors | 8.3yrs | no data | no data | |
Member of Scientific & Medical Alliance Board | 5.8yrs | no data | no data | |
Member of Scientific & Medical Alliance Board | 5.8yrs | no data | no data | |
Member of Scientific & Medical Alliance Board | 5.8yrs | no data | no data | |
Member of Scientific & Medical Alliance Board | 5.8yrs | no data | no data |
7.0yrs
Average Tenure
64yo
Average Age
Experienced Board: BTCY's board of directors are considered experienced (7 years average tenure).